Molecular Characterization of HER2-Low Invasive Breast Carcinoma by Quantitative RT-PCR Using Oncotype DX Assay

BACKGROUND: HER2 immunohistochemistry (IHC) reproducibility is suboptimal for HER-low cases (IHC 1+ or 2+). METHODS: The Yale cohort included 214 stages I-II estrogen receptor positive breast cancers with IHC scores 0, 1+, and 2+ and routine Oncotype DX Recurrence Score (RS) results. The Exact Scien...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hao-Kuen, Can, Thuy, Kahn, Adriana, Flannery, Cynthia A, Hoag, Jess, Akkunuri, Alekhya, Bailey, Helen, Baehner, Rick, Pusztai, Lajos, Rozenblit, Mariya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546821/
https://www.ncbi.nlm.nih.gov/pubmed/37656608
http://dx.doi.org/10.1093/oncolo/oyad249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546821/
https://www.ncbi.nlm.nih.gov/pubmed/37656608
http://dx.doi.org/10.1093/oncolo/oyad249

Ejemplares similares